These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
526 related articles for article (PubMed ID: 28931215)
21. NF-κB and JNK mediated apoptosis and G Zeng GZ; Wang Z; Zhao LM; Fan JT; Tan NH J Ethnopharmacol; 2018 Jun; 220():220-227. PubMed ID: 29097252 [TBL] [Abstract][Full Text] [Related]
22. Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways. Hatashita M; Taniguchi M; Baba K; Koshiba K; Sato T; Jujo Y; Suzuki R; Hayashi S Int J Mol Med; 2014 Feb; 33(2):406-14. PubMed ID: 24285252 [TBL] [Abstract][Full Text] [Related]
23. Linalool induces cell cycle arrest and apoptosis in HepG2 cells through oxidative stress generation and modulation of Ras/MAPK and Akt/mTOR pathways. Rodenak-Kladniew B; Castro A; Stärkel P; De Saeger C; García de Bravo M; Crespo R Life Sci; 2018 Apr; 199():48-59. PubMed ID: 29510199 [TBL] [Abstract][Full Text] [Related]
24. Distinct genetic alterations in the mitogen-activated protein kinase pathway dictate sensitivity of thyroid cancer cells to mitogen-activated protein kinase kinase 1/2 inhibition. Schweppe RE; Kerege AA; Sharma V; Poczobutt JM; Gutierrez-Hartmann A; Grzywa RL; Haugen BR Thyroid; 2009 Aug; 19(8):825-35. PubMed ID: 19500021 [TBL] [Abstract][Full Text] [Related]
25. Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK/ERK and PI3K/AKT pathways via distinct mechanisms. Su X; Shen Z; Yang Q; Sui F; Pu J; Ma J; Ma S; Yao D; Ji M; Hou P Theranostics; 2019; 9(15):4461-4473. PubMed ID: 31285773 [No Abstract] [Full Text] [Related]
26. Anti-liver cancer effect and the mechanism of arsenic sulfide in vitro and in vivo. Wang S; Zhang C; Li Y; Li P; Zhang D; Li C Cancer Chemother Pharmacol; 2019 Mar; 83(3):519-530. PubMed ID: 30542770 [TBL] [Abstract][Full Text] [Related]
27. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway. Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811 [TBL] [Abstract][Full Text] [Related]
28. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1. Bhowmik T; Gomes A Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778 [TBL] [Abstract][Full Text] [Related]
29. PKI 166 induced redox signalling and apoptosis through activation of p53, MAP kinase and caspase pathway in epidermoid carcinoma. Das S; Dey KK; Bharti R; MaitiChoudhury S; Maiti S; Mandal M J Exp Ther Oncol; 2012; 10(2):139-53. PubMed ID: 23350354 [TBL] [Abstract][Full Text] [Related]
30. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine. Zheng F; Tang Q; Wu J; Zhao S; Liang Z; Li L; Wu W; Hann S J Exp Clin Cancer Res; 2014 Apr; 33(1):36. PubMed ID: 24766860 [TBL] [Abstract][Full Text] [Related]
31. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo. Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863 [TBL] [Abstract][Full Text] [Related]
32. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling. Wang Z; Jiang C; Ganther H; Lü J Cancer Res; 2001 Oct; 61(19):7171-8. PubMed ID: 11585751 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of migration and invasion by berberine via inactivation of PI3K/Akt and p38 in human retinoblastoma cell line. Wang Y; Yuan J; Yang L; Wang P; Wang X; Wu Y; Chen K; Ma R; Zhong Y; Guo X; Gong Y; Gui M; Jin Y Adv Clin Exp Med; 2018 Jul; 27(7):899-905. PubMed ID: 29790698 [TBL] [Abstract][Full Text] [Related]
34. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells. Shukla S; Rizvi F; Raisuddin S; Kakkar P Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467 [TBL] [Abstract][Full Text] [Related]
35. Berberine induces G1 arrest and apoptosis in human glioblastoma T98G cells through mitochondrial/caspases pathway. Eom KS; Hong JM; Youn MJ; So HS; Park R; Kim JM; Kim TY Biol Pharm Bull; 2008 Apr; 31(4):558-62. PubMed ID: 18379040 [TBL] [Abstract][Full Text] [Related]
36. 13-acetoxysarcocrassolide induces apoptosis on human gastric carcinoma cells through mitochondria-related apoptotic pathways: p38/JNK activation and PI3K/AKT suppression. Su CC; Chen JY; Din ZH; Su JH; Yang ZY; Chen YJ; Wang RY; Wu YJ Mar Drugs; 2014 Oct; 12(10):5295-315. PubMed ID: 25342459 [TBL] [Abstract][Full Text] [Related]
37. Bufalin induces G0/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells. Huang WW; Yang JS; Pai SJ; Wu PP; Chang SJ; Chueh FS; Fan MJ; Chiou SM; Kuo HM; Yeh CC; Chen PY; Tsuzuki M; Chung JG Mutat Res; 2012 Apr; 732(1-2):26-33. PubMed ID: 22285700 [TBL] [Abstract][Full Text] [Related]
38. Apoptosis Activation in Thyroid Cancer Cells by Jatrorrhizine-Platinum(II) Complex via Downregulation of PI3K/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Lu K; Wei W; Hu J; Wen D; Ma B; Liu W; Wang Y; Lu Z Med Sci Monit; 2020 Apr; 26():e922518. PubMed ID: 32341329 [TBL] [Abstract][Full Text] [Related]
39. Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines. Piscazzi A; Costantino E; Maddalena F; Natalicchio MI; Gerardi AM; Antonetti R; Cignarelli M; Landriscina M J Clin Endocrinol Metab; 2012 Jun; 97(6):E898-906. PubMed ID: 22442268 [TBL] [Abstract][Full Text] [Related]
40. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma. Santarpia L; Myers JN; Sherman SI; Trimarchi F; Clayman GL; El-Naggar AK Cancer; 2010 Jun; 116(12):2974-83. PubMed ID: 20564403 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]